Line Bjørge - Concepedia

Author

Line Bjørge

Also Known As

A. Goossens, Alvaro Cabrera Garcia, Andrew Berchuck, Bjørge, Line, Camilla Krakstad, Diana M. Eccles, Elena Braicu, Elisabeth Wik, Helga B. Salvesen, Irene Orlow

310

Publications

Citations

H-Index

126

Concepts

All Affiliations

Haukeland University Hospital University of Bergen Norwegian University of Science and Technology Oslo University Hospital St Olav's University Hospital

About

Line Bjørge is an author at Haukeland University Hospital specializing in medicine, obstetrics, and ovarian cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	37	3.2K
2	Public Health	12	12	601
3	Health Sciences	2	2	58
4	Engineering	1	1	16
5	Social Sciences	1	1	64

Line Bjørge

102

Publications

6.6K

Citations

H-Index

Page 1

	Year	Citations
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk Ganna Chornokur, Hui‐Yi Lin, Jonathan P. Tyrer, PLoS ONE	2015	901
Landscape of genomic alterations in cervical carcinomas Akinyemi I. Ojesina, Lee Lichtenstein, Samuel S. Freeman, Nature Cervical CancerPathologyCancer GenomicsMedicineGenomic Alterations	2013	866
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial Mansoor Raza Mirza, Elisabeth Åvall Lundqvist, Michael J. Birrer, The Lancet Oncology Superiority TrialMedicineGynecologyCancer TreatmentPhase 2	2019	239
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial Andreas du Bois, Gunnar B. Kristensen, Isabelle Ray‐Coquard, The Lancet Oncology Placebo-controlled Phase 3MedicineMetronomic TherapyGynecologyStandard First-line Chemotherapy	2015	207
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis William J. Gibson, Erling A. Høivik, Mari K. Halle, Nature Genetics OncologyTumor HeterogeneityGenomic LandscapeMedicineGynecology	2016	201
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García, The Lancet OncologyCervical CancerMetronomic TherapyPathologyRecurrent Cervical Cancer	2023	175
Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study Nuno R. Nené, Daniel Reisel, Andreas Leimbach, The Lancet Oncology Cancer RiskCancer EpidemiologyMedicineBrca1 Mutation StatusGynecology	2019	153
Ascitic complement system in ovarian cancer Line Bjørge, Juha Hakulinen, OK Vintermyr, British Journal of Cancer Cancer ImmunosurveillanceEndocrine-related CancerMedicineImmunologyPathology	2005	129
Shared heritability and functional enrichment across six solid cancers Xia Jiang, Hilary K. Finucane, Fredrick R. Schumacher, Nature Communications	2019	123
Preoperative tumor texture analysis on MRI predicts high‐risk disease and reduced survival in endometrial cancer Sigmund Ytre‐Hauge, Julie A. Dybvik, Arvid Lundervold, Journal of Magnetic Resonance Imaging	2018	121

Page 1